← SynDRA
BMS-191095
SynDRA canonical compound SYN0000494 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Mechanism of action | KATP activator | potassium channel agonist |
|---|
All known targets
Mechanisms of action (all sources)
- KATP activator
- potassium channel agonist
- ABCC9 MODULATOR
Cross-references
Synonyms
- BMS-199080
- K6V527OYN8
- BMS191095
- RefChem:120702
- UNII-K6V527OYN8
- C22H21ClN4O2
- orb1309919
- SCHEMBL8896325
- BDBM50409914
- MFCD25977742
- AKOS030526638
- CS-5470
- BMS-191095?
- DA-61767
- HY-14256
- MS-27034
- F85365
- T10566
- BRD-K01231377-001-01-8
- 3I2CFR0UVU
- BMS191095 monohydrochloride;BMS 191095 monohydrochloride
- orb2945420
- UNII-3I2CFR0UVU
- T204668
- HY-14257
- BMS-191095 hydrochloride, >=98% (HPLC)
- RefChem:199937
- BMS-191095 hydrochloride
- BMS-191095 (monohydrochloride)
- SCHEMBL4260440
- BMS-191095 (hydrochloride)
Look up BMS-191095 in the interactive SynDRA portal →